Human Epidermal Growth Factor Receptor 2-Immunohistochemical-Breast Cancer Cells

BOND™ ORACLE™ Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemical (IHC) System

The BOND™ ORACLE™ Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemical (IHC) System is a laboratory test that measures how much HER2 protein is being made by breast cancer cells. The test uses a technique that will specifically recognize.. (Approved: 4/13/2012) (Source: Medical Device Approvals) read more..

source:http://www.medworm.com

Epidermal Growth Factor Receptor-Consumer Information-Immunohistochemical-Breast Cancer Cells

Consumer Information on: BOND? ORACLE? Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemical (IHC) System - P090015

The BOND? ORACLE? Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemical (IHC) System is a laboratory test that measures how much HER2 protein is being made by breast cancer cells. The test uses a technique that will specifically recognize.. (Source: Food and Drug Adminstration (FDA): CDRHNew) read more..

source:http://www.medworm.com

Amplified in breast cancer 1 oncogene enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways

Conclusion: AIB1 plays an important role in proliferation and chemoresistance of CCA through simultaneous activation of Akt and Nrf2 pathways, suggesting that AIB1 is a potential molecular target for CCA treatment. (HEPATOLOGY 2012) (Source: Hepatology) read more..

source:http://www.medworm.com